Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Marson

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
BMC Neurology|December 4, 2022
Correction: Increased volume of cerebral oedema is associated with risk of acute seizure activity and adverse neurological outcomes in encephalitis - regional and volumetric analysis in a multi-centre cohortAli M Alam, Jian P K Chen, Greta K Wood, et al.
BMC Neurology|November 7, 2022
Increased volume of cerebral oedema is associated with risk of acute seizure activity and adverse neurological outcomes in encephalitis - regional and volumetric analysis in a multi-centre cohortAli M Alam, Jian P K Chen, Greta K Wood, et al.
The Lancet. Rheumatology|May 10, 2021
Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica secondary to herniated lumbar disc (NERVES): a phase 3, multicentre, open-label, randomised controlled trial and economic evaluationMartin John Wilby, Ashley Best, Eifiona Wood, et al.
Lancet (London, England)|April 11, 2021
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trialAnthony Marson, Girvan Burnside, Richard Appleton, et al.
Lancet (London, England)|April 11, 2021
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trialAnthony Marson, Girvan Burnside, Richard Appleton, et al.
Health Technology Assessment (Winchester, England)|April 13, 2021
Microdiscectomy compared with transforaminal epidural steroid injection for persistent radicular pain caused by prolapsed intervertebral disc: the NERVES RCTMartin J Wilby, Ashley Best, Eifiona Wood, et al.
Epilepsia|September 2, 2021
Exploring the prevalence and profile of epilepsy across Europe using a standard retrospective chart review: Challenges and opportunitiesChristine Linehan, Ailbhe Benson, Alex Gunko, et al.
European Journal of Neurology|October 21, 2024
Brain health and national neurological societies: Results of the European Academy of Neurology survey on brain health awareness and areas of implementation for European countriesMatilde Leonardi, Isabella Colonna, David Garcia-Azorin, et al.
Seizure|January 22, 2025
Top Ten epilepsy research priorities: A UK priority setting partnershipAnna C Norton, Caoimhe Twohig-Bennett, Maxine Smeaton, et al.
Clinical Pharmacology and Therapeutics|May 9, 2019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity ReactionsPaola Nicoletti, Sarah Barrett, Laurence McEvoy, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
BMC Neurology|December 4, 2022
Correction: Increased volume of cerebral oedema is associated with risk of acute seizure activity and adverse neurological outcomes in encephalitis - regional and volumetric analysis in a multi-centre cohortAli M Alam, Jian P K Chen, Greta K Wood, et al.
BMC Neurology|November 7, 2022
Increased volume of cerebral oedema is associated with risk of acute seizure activity and adverse neurological outcomes in encephalitis - regional and volumetric analysis in a multi-centre cohortAli M Alam, Jian P K Chen, Greta K Wood, et al.
The Lancet. Rheumatology|May 10, 2021
Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica secondary to herniated lumbar disc (NERVES): a phase 3, multicentre, open-label, randomised controlled trial and economic evaluationMartin John Wilby, Ashley Best, Eifiona Wood, et al.
Lancet (London, England)|April 11, 2021
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trialAnthony Marson, Girvan Burnside, Richard Appleton, et al.
Lancet (London, England)|April 11, 2021
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trialAnthony Marson, Girvan Burnside, Richard Appleton, et al.
Health Technology Assessment (Winchester, England)|April 13, 2021
Microdiscectomy compared with transforaminal epidural steroid injection for persistent radicular pain caused by prolapsed intervertebral disc: the NERVES RCTMartin J Wilby, Ashley Best, Eifiona Wood, et al.
Epilepsia|September 2, 2021
Exploring the prevalence and profile of epilepsy across Europe using a standard retrospective chart review: Challenges and opportunitiesChristine Linehan, Ailbhe Benson, Alex Gunko, et al.
European Journal of Neurology|October 21, 2024
Brain health and national neurological societies: Results of the European Academy of Neurology survey on brain health awareness and areas of implementation for European countriesMatilde Leonardi, Isabella Colonna, David Garcia-Azorin, et al.
Seizure|January 22, 2025
Top Ten epilepsy research priorities: A UK priority setting partnershipAnna C Norton, Caoimhe Twohig-Bennett, Maxine Smeaton, et al.
Clinical Pharmacology and Therapeutics|May 9, 2019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity ReactionsPaola Nicoletti, Sarah Barrett, Laurence McEvoy, et al.
Pageof 7